Medicine News and Research

RSS

First-in-kind study evaluates health outcomes of women sexual assault survivors

One in 5 U.S. women experience sexual assault during their lifetime, yet little is known about the experiences and health outcomes of sexual assault survivors. A new study seeks to change that.

30 Sep 2014

Bausch + Lomb’s sub-micron loteprednol etabonate ophthalmic gel meets primary endpoint

Bausch + Lomb, a wholly owned subsidiary of Valeant Pharmaceuticals International, Inc. (NYSE: VRX and TSX: VRX), today announced that its next generation sub-micron gel formulation of loteprednol etabonate was statistically superior to placebo (vehicle gel) in eliminating inflammation and pain following cataract surgery by study day eight, the primary endpoints in the first Phase 3, multi-center, double-masked, vehicle-controlled, parallel-group study.

30 Sep 2014

Aspen Dental expands operations with a new dental office in Hermitage, Tennessee

A new Aspen Dental office is opening in Hermitage, TN on Thursday, October 2. Located at 4054 Lebanon Pike, the conveniently located practice will provide dental services that range from implant services and dentures to general dentistry and restoration.

30 Sep 2014

New approach to solve global challenges in food security, emerging diseases and biodiversity loss

Solving global challenges in food security, emerging diseases and biodiversity loss requires evolutionary thinking, argues a new study published online in Science Express that was co-authored by Bruce Tabashnik of the University of Arizona College of Agriculture and Life Sciences.

30 Sep 2014

Pharmacy Value Management Solutions and Jeff Liva sign marketing deal

Advanzeon Solutions, Inc., ("Advanzeon" or the "Company"), which provides behavioral health, wellness, pharmacy management services and sleep apnea programs, to employers, Taft-Hartley health and welfare funds, managed care companies throughout the U.S. today announced that its wholly-owned subsidiary, Pharmacy Value Management Solutions, Inc. ("PVMS"), has entered into a marketing agreement (the "Agreement") with Jeff Liva & Co. ("Dr. Liva"), whereby Dr. Liva, through his Preventive PLUS division will, among other things, introduce the Company's programs to his existing and potential clients and recommend the programs for inclusion in his clients' healthcare benefit packages.

30 Sep 2014

Targeted treatments may improve idiopathic PAH survival

Patients with idiopathic pulmonary arterial hypertension may live longer if they are given targeted treatments than if they receive conventional management, researchers suggest.

29 Sep 2014

Increasing prevalence of obstructive sleep apnea threatens public health and safety

Public health and safety are threatened by the increasing prevalence of obstructive sleep apnea, which now afflicts at least 25 million adults in the U.S., according to the National Healthy Sleep Awareness Project. Several new studies highlight the destructive nature of obstructive sleep apnea, a chronic disease that increases the risk of high blood pressure, heart disease, Type 2 diabetes, stroke and depression.

29 Sep 2014

Targeted combination drug therapy can extend life, halt disease in metastatic melanoma patients

A world-first study in today's New England Journal of Medicine heralds the efficacy of a targeted combination drug therapy after reporting major declines in the risk of disease progression and death in people with metastatic melanoma.

29 Sep 2014

Montefiore-Einstein selected to conduct multi-site cancer clinical trials

Montefiore Einstein Center for Cancer Care and Albert Einstein College of Medicine of Yeshiva University have been awarded a $3.4 million grant from the National Cancer Institute to conduct multi-site cancer clinical trials and research focused on reducing healthcare disparities in cancer care.

29 Sep 2014

Christiana Care Health System wins 2014 Health Devices Achievement Award

ECRI Institute is pleased to announce Christiana Care Health System, Wilmington, DE, as the winner of its 9th Annual Health Devices Achievement Award.

29 Sep 2014

Spring Mountain Capital leads financing round for Oncoceutics with additional private investors' participation

Spring Mountain Capital, LP, a New York-based investment management firm, announced today that its private equity group structured and led a financing round for Oncoceutics, Inc. with additional private investors' participation.

29 Sep 2014

Docs express frustration with electronic health records

And some worry that a slate of new Web domain addresses could trick consumers into taking medical advice from and getting scammed by those without the proper credentials.

29 Sep 2014

Tianyin Pharmaceutical's Qionglai Facility completes official GMP site visit by CFDA

Tianyin Pharmaceutical Co., Inc., a pharmaceutical company that specializes in patented biopharmaceutical, modernized traditional Chinese medicine (mTCM), branded generics and active pharmaceutical ingredients (API), today announced that its Qionglai Facility (QLF) has successfully completed the official site visit by the China Food & Drug Administration's (CFDA) for its Good Manufacturing Practice (GMP) certification.

29 Sep 2014

Bigger challenges forecast for health law's second enrollment drive

Enrolling new customers will be more complicated this time around because potential enrollees may be harder to reach, reports The Wall Street Journal.

29 Sep 2014

Dabrafenib shows significant anti-tumour activity in BRAF V600E mutant non-small cell lung cancer

The BRAF inhibitor dabrafenib has significant anti-tumour activity in patients with advanced BRAF V600E mutant non-small cell lung cancer whose disease has progressed after chemotherapy, according to phase II data presented at the ESMO 2014 Congress in Madrid, Spain.

29 Sep 2014

OSU engineers develop simple device to improve hand function after surgery

Engineers at Oregon State University have developed and successfully demonstrated the value of a simple pulley mechanism to improve hand function after surgery.

29 Sep 2014

Aptose joins Beat AML research collaboration

Aptose Biosciences Inc., a clinical-stage company developing new therapeutics and molecular diagnostics that target the underlying mechanisms of cancer, the Knight Cancer Institute at Oregon Health & Science University and The Leukemia & Lymphoma Society today announced that Aptose has joined the Beat AML collaboration.

29 Sep 2014

New AliveECG app provides patients with free real-time AF detection in ECG recordings

AliveCor, Inc. announced today the launch of the latest version of the AliveECG app, which provides patients with free real-time atrial fibrillation (AF) detection in ECG recordings using its new FDA-cleared algorithm.

29 Sep 2014

Survey: Many patients not always well informed about treatment options

More than three quarters of oncology specialists in Europe, South America and Asia believe their patients are not always well enough informed about the treatment options available to them, survey results have revealed at the ESMO 2014 Congress in Madrid, Spain.

29 Sep 2014

Cediranib combined with chemotherapy improves survival in recurrent cervical cancer

For patients with cervical cancer that has recurred after treatment or has spread elsewhere in the body, adding the experimental drug cediranib to standard chemotherapy improves tumour shrinkage and adds a modest improvement in progression-free survival, researchers report at the ESMO 2014 Congress in Madrid.

29 Sep 2014

Medicine News and Research

First-in-kind study evaluates health outcomes of women sexual assault survivors

Bausch + Lomb’s sub-micron loteprednol etabonate ophthalmic gel meets primary endpoint

Aspen Dental expands operations with a new dental office in Hermitage, Tennessee

New approach to solve global challenges in food security, emerging diseases and biodiversity loss

Pharmacy Value Management Solutions and Jeff Liva sign marketing deal

Targeted treatments may improve idiopathic PAH survival

Increasing prevalence of obstructive sleep apnea threatens public health and safety

Targeted combination drug therapy can extend life, halt disease in metastatic melanoma patients

Montefiore-Einstein selected to conduct multi-site cancer clinical trials

Christiana Care Health System wins 2014 Health Devices Achievement Award

Spring Mountain Capital leads financing round for Oncoceutics with additional private investors' participation

Docs express frustration with electronic health records

Tianyin Pharmaceutical's Qionglai Facility completes official GMP site visit by CFDA

Bigger challenges forecast for health law's second enrollment drive

Dabrafenib shows significant anti-tumour activity in BRAF V600E mutant non-small cell lung cancer

OSU engineers develop simple device to improve hand function after surgery

Aptose joins Beat AML research collaboration

New AliveECG app provides patients with free real-time AF detection in ECG recordings

Survey: Many patients not always well informed about treatment options

Cediranib combined with chemotherapy improves survival in recurrent cervical cancer

Everything there is to know about biosimilars eBook

Improving healthcare sustainability through carbon data

Managing vibration in IVF laboratories

A New Approach to Preventing Bladder Cancer Recurrence

Latest News